Metagenomic next-generation sequencing-guided antimicrobial treatment versus conventional antimicrobial treatment in early severe community-acquired pneumonia among immunocompromised patients (MATESHIP): A study protocol

Metagenomic next-generation sequencing-guided antimicrobial treatment versus conventional antimicrobial treatment in early severe community-acquired pneumonia among immunocompromised patients (MATESHIP): A study protocol

BackgroundSevere community-acquired pneumonia (SCAP) is the main cause of mortality in immunocompromised patients. Compared with conventional microbiological tests (CMT), metagenomic next-generation sequencing (mNGS) can quickly and simultaneously detect a wide array of bacteria, viruses, and fungi...

Descrizione completa

Dettagli Bibliografici
Autori principali: Shaohua Fan, Min Si, Nana Xu, Meichen Yan, Mingmin Pang, Guangfeng Liu, Jibin Gong, Hao Wang
Natura: Articolo
Lingua:English
Pubblicazione: Frontiers Media S.A. 2022-08-01
Serie:Frontiers in Microbiology
Soggetti:
metagenomic next generation sequencing
immunosuppression
immunocompromised patient
community-acquired pneumonia
antimicrobial therapy
Accesso online:https://www.frontiersin.org/articles/10.3389/fmicb.2022.927842/full

Accesso online

https://www.frontiersin.org/articles/10.3389/fmicb.2022.927842/full

Documenti analoghi